Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 196.25
+7.70 (4.08%)
At close: Jun 12, 2026
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 53.45 billion as of June 12, 2026. Its market cap has increased by 5.09% in one year.
Market Cap
53.45B
Enterprise Value
60.49B
Revenue
34.09B
Ranking
n/a
PE Ratio
22.66
Stock Price
196.25
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 53.45B, an increase of 251.29%. That is a compound annual growth rate of 4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 53.45B | -10.31% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.19B |
| Elekta AB | 20.02B |
| Nolato AB | 13.19B |
| Vitrolife AB | 12.97B |
| Xvivo Perfusion AB | 8.60B |
| MedCap AB | 7.47B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |